Entry for:Research in a nutshell
Sleep apnoea is a sleep related breathing disorder that involves a decrease or complete halt of airflow. It is a serious and prevalent health issue affecting quality of life associated with a high rate of mortality and morbidity. If it remains untreated, the consequences are immense such as cardiac disorders, heart failure and physiological, psychological and financial sever costs. It is estimated that anywhere up to 15% of the population have sleep apnoea and many suffer from daytime sleepiness and fatigue which may be a symptom of disturbed sleep pattern.
Thus, it is vigorously needed to be treated. The standard treatment is CPAP (continuous positive airway pressure) which basically operates like an inverse vacuum cleaner and pumps the air into the airway to keep it open. There are other treatment options such as surgery, medication and oral appliances. At the Sleep Research Group in Charles Perkins Centre, the University of Sydney, we believe that as people are different, so are the causes, symptoms, anatomies and clinical parameters. The aim of this research is to personalise the therapy for sleep apnoea and provide every individual with the best treatment option to reduce the cost and improve the treatment outcome.